FAST Graphs

Research & Analysis — Freemium

Visual stock valuation tool that charts earnings against price for value investors

The orange earnings line that shows valuation visually on a single chart

Overview

FAST Graphs is a visual stock valuation tool that plots a company's earnings, cash flow, sales, and dividends against its share price, built for value investors who want to see overvaluation or undervaluation at a glance instead of running the math by hand. This FAST Graphs review treats it as a research and analysis tool, not a trading platform — something you open before you buy a stock, not while you're in a trade. The orange earnings line is the reference point: price above it signals a rich multiple, price below it signals a cheap one.

The chart format is the real selling point. Valuation is readable at a glance from one chart, cutting out the mental math of comparing price-to-earnings ratios across companies in your head. Coverage runs deep too, spanning more than 17,000 symbols, so most stocks a retail investor would research are in the database. The plan starts at $19.95/mo on a freemium model with a free trial, and annual billing brings that down to $15.95 a month if you commit for the year.

The limitations matter. FAST Graphs shows only a single Trustpilot review, thin outside validation for a tool asking you to trust its read over your own spreadsheet. The chart conventions also take real time to learn — the orange line, the forecast segments, and the FG Score aren't obvious on day one, and a new user can misread the chart before the logic clicks. There's no API access and no mobile app, so this stays a desktop research tool, not something you'd check from your phone.

Coverage is US stocks only, and the design points toward long-term investing, not active trading — this is for building conviction on a position you plan to hold, not timing an entry. Automation is manual throughout: you read and decide, nothing screens or executes for you. Skip it if you trade international markets, need a mobile app, want automation, or you're a beginner who'd rather start with a simpler valuation screen first. For a patient, US-focused investor doing real homework on a stock, it earns its price.

Pros

Cons